2D–shear-wave elastography example: non-MAFLD CKD case (male, 54 years). gan Zienab M. Saad (22676502)

Awduron Eraill:

2D–shear-wave elastography example: MAFLD + CKD case (male, 65 years). gan Zienab M. Saad (22676502)

Awduron Eraill:

eGFR in the study participants. gan Zienab M. Saad (22676502)

Awduron Eraill:

Demographic and Clinical Characteristics of Study Participants. gan Zienab M. Saad (22676502)

Awduron Eraill:

Stratification of Liver Stiffness according to eGFR in the MAFLD group. gan Zienab M. Saad (22676502)

Awduron Eraill:

Medication-inclusive multivariable logistic regression for MAFLD. gan Zienab M. Saad (22676502)

Awduron Eraill:

Receiver operating characteristic (ROC) curve analysis comparing the performance of non-invasive fibrosis scores in MAFLD patients. gan Zienab M. Saad (22676502)

Awduron Eraill:

Comparison of Non-invasive Liver Fibrosis Scores. gan Zienab M. Saad (22676502)

Awduron Eraill:

A. Violin plots showing eGFR distribution in MAFLD (red) vs. non-MAFLD (blue) groups. gan Zienab M. Saad (22676502)

Awduron Eraill:

Proposed pathophysiological crosstalk between MAFLD and CKD. gan Zienab M. Saad (22676502)

Awduron Eraill:

Liver Stiffness and Fibrosis Grading by MAFLD Status. gan Zienab M. Saad (22676502)

Awduron Eraill:

2D–shear-wave elastography example: MAFLD + CKD case (female, 57 years). gan Zienab M. Saad (22676502)

Awduron Eraill:

Grades of liver fibrosis in MAFLD group (grey) and non-MAFLD group (black). gan Zienab M. Saad (22676502)

Awduron Eraill:

Multivariable logistic regression models for MAFLD predictors. gan Zienab M. Saad (22676502)

Awduron Eraill:

Liver Fibrosis Characteristics by CKD Stage in MAFLD Patients (n = 64). gan Zienab M. Saad (22676502)

Awduron Eraill: